4 listed pharma including Seoul Pharma spend more than 50% of their sales into SG&A
One of 3 listed pharmaceutical companies reportedly send 40% of their sales into selling, general and administrative(SG&A) expenses. Particularly, 4 companies, such as Seoul Pharma, Jin Yang Pharmaceutical, Korea Arlico Pharm and Dongkoo Bio&Pharma spent a half of their sales into the expenses....
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.